Navigation Links
OHSU School of Dentistry team discovers new molecule in blood-pressure control system
Date:1/8/2009

.

Balkowiec and her team found that the stimulation of baroreceptors, as experienced during an increase in blood pressure, leads to the release of BDNF. The study also discovered that BDNF is present at the central end of baroreceptors in the brainstem.

"In fact, BDNF is likely to play the most important role at the central end of baroreceptors, where they connect to second-order neurons in the blood-pressure control pathway," said Balkowiec. "BDNF has previously been shown to play an important role in establishing neuronal connections in other parts of the nervous system, but this is the first time it has been considered a factor in the blood pressure control system."

Studies under way, in collaboration with Virginia Brooks, Ph.D., OHSU School of Medicine professor of physiology and pharmacology, indicate that levels of BDNF in cardiorespiratory nerve cells increase dramatically when blood pressure rises. This suggests a direct role of BDNF in regulation of blood pressure, said Balkowiec.


'/>"/>

Contact: Sydney Clevenger
clevenge@ohsu.edu
503-418-1792
Oregon Health & Science University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Time to Set Kids Back-to-School Sleep Clocks
2. Add Earlier Bedtime to Back-to-School List
3. Does Pathological Shyness Make for School Shooters?
4. Mailman School of Public Health study examines link between racial discrimination and substance use
5. Survey reveals disparities in skin cancer knowledge, protection among high school students
6. Non-medicinal treatment touted for pre-schoolers with ADHD
7. Nonmedicinal treatment touted for preschoolers with ADHD
8. Obese Children Miss More School Days
9. Back to School Means Backpack Safety
10. Heart Attacks at School Involve More Adults Than Kids
11. Back to School Means Return of School Blood Drives

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...f a statistically significant survival benefit fro... receptor (ER)-positive tumors had high levels of ...ha S118-P), according to a brief communication pub...ational Cancer Institute . , Approximately 50% o...eclinical studies have shown that ER-alpha S118-P ...
(Date:11/25/2009)...short to draw definite conclusions, experts say, ...-- In diabetic patients with blocked coronary arte...s at one year whether patients undergo bypass surg...ers report. , Bypass surgery has been the stand...artery disease. However, less invasive approaches ...
(Date:11/25/2009)...others to overlook needed care, study finds , ...other,s depression can worsen her child,s asthma, ...study of 262 black mothers and their children foun...symptoms had more frequent asthma symptoms, while ... had less frequent asthma symptoms. , The Johns...
(Date:11/25/2009)...- MISSIONSkincare ®isproudtosupportGNC,seffor...annualSt.Jude ThanksandGiving campaign,$1fromthepu...(TM)LipBalm willbedonatedtoSt.Jude.Additionally,GN...ionatcheckoutatoneoftheir5,000+retaillocationsorat...duringtheir2009 ThanksandGiving campaign. ,, "W...
(Date:11/25/2009)...ine carried into the body on a carefully engineere...sfully eliminate tumors in mammals, scientists rep...l Medicine . , The new approach, pioneered by bi..., uses plastic disks impregnated with tumor-specif...ram the mammalian immune system to attack tumors. ...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
... education come fewer chronic problems, study find...eople who are wealthy and educated appear to have ...ife. , Researchers from the British Economic &...cated were less likely to have depression, high-bl...
..., May 18 Combining two chemotherapy drugs with tr...static HER2+ breast cancer may offer physicians an...he 45th Annual Meeting of the American Society o...stuzumab offers a treatment option that is at leas...
...18 A medication that helps stop the growth of new...some patients with aggressive thyroid cancer, rese...nnual meeting of the American Society of Clinica...th the drug pazopanib either stopped growing, or q...
... officials say the disease is no more dangerous th...ay News) -- While most cases of swine flu continue...from the new H1N1 virus is slightly higher than th... than seasonal influenza, but not necessarily subs...
...8 Dr. Andree Bates, President of the Pharmaceutic... MasterClass on how to tell if you are making the ...s, WHAT: MasterClass on the latest techniques... 12 June 2009, WHERE: 1 Northumberland Avenue,...
...frican-American women who were younger at menarche...re likely to report a history of childhood sexual ...r at Boston University,s Slone Epidemiology Center... The study, which appears currently on-line in th...
Other Medicine News:Health News:Money May Matter, Health-Wise, in Old Age 2Health News:Mayo Clinic Researchers Say Triple Drug Combination is Promising Option to Treat Metastatic HER2+ Breast Cancer 2Health News:Mayo Clinic Researchers Say Triple Drug Combination is Promising Option to Treat Metastatic HER2+ Breast Cancer 3Health News:Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer, Mayo Clinic Researchers Report 2Health News:Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer, Mayo Clinic Researchers Report 3Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 2Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 3Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 4Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 5Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 6Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 7Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 8Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 9Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 10Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 11Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 12Health News:Swine Flu Fatality Rate 'Little Bit' Higher Than That of Seasonal Flu 13Health News:MEDIA ALERT - Eularis to Hold Pharmaceutical Marketing ROI MasterClass in London 2Health News:Study finds higher prevalence of early menarche among survivors of childhood sexual abuse 2
(Date:11/24/2009)...ewswire-FirstCall/--Vermillion,Inc.(VRML)(PinkShee...zationandDisclosureStatementtoday,November24,2009,...Delaware.AhearingtoconsiderapprovaloftheDisclosure...hthehearingontheconfirmationofthePlanscheduledforJ...allclaimsinfull.ThePlanisexpected,ifapproved,toall...
(Date:11/24/2009)...wire/--Inadditiontofamily,friendsandhealth,cancers...rThanksgivinggratitudelist. ,, "Theyheardthefac...dofMonday,sverdictstotaling$103millionindamagesaga...000womennationwidewhohavesuedWyethandPfizerpharmac...Prempro.Wisneskiandtheothervictimsofhormonetherapy...
(Date:11/24/2009)...ewswire/--ZargisMedicalCorp.,asubsidiaryofSpeedusC...eResearch(NYSE: SI ),todayannouncedthatitsZargisCa...deofCBS, TheEarlyShow duringasegmentinwhichMarkJan...vewinningproductsfromthepublication,s2009"BestofWh...edtelevisionmorningnewstalkshowbroadcastbyCBSfromN...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Maryland Woman Thankful for Wyeth Verdicts 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 31 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 11 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 21 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 31 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 4Cell Therapeutics Inc 28CTI 29 to Report Third Quarter Financial Results on November 5 60483 1Lupus Research Institute 3A Benlysta 28TM 29 Trial Results in an Historic Research Breakthrough and Victory for People With Lupus 14678 1Lupus Research Institute 3A Benlysta 28TM 29 Trial Results in an Historic Research Breakthrough and Victory for People With Lupus 14678 2
... EnVivo Pharmaceuticals, Inc.,a privately held bio...egenerative diseases, today announced progress on ...chizophrenia and Huntington,s,diseases. EnVivo Ph...orally,active Alpha 7 Nicotinic Acetylcholine Rece...ts associated with Alzheimer,s disease and,Schizop...
...h Joint Venture Between Bristol-Myers Squibb, Co...n HIV Treatment -, PRINCETON, N.J. and FOSTER CIT...ol-Myers Squibb Company (NYSE: BMY ) and Gilead S...t Health Canada has approved ATRIPLA(R),(efavirenz...fumarate 300,mg) for the treatment of HIV-1 infect...
Other Medicine Technology:EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimer's, Schizophrenia and Huntington's Diseases 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 3Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 4Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 5Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 6Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 7Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 8Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 9
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: